DS-1594a·HCl and DS-1594a·succinate also exhibited antitumor efficacy in MOLM-13 xenograft, NPM1c-mutated AML-PDX, and MLL1-r ALL-PDX models in vivo. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.